¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù.
Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº ¿ÃÇØ npj vaccines ¿¡ ÃâÆǵÈ
"Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
" ÀÔ´Ï´Ù.
ÀÌ ³í¹®Àº ÀÓ»óÀûÀ¸·Î »ç¿ëµÉ ¼ö ÀÖ´Â adjuvant 5°¡Áö (Alum, AS03, AS37, CpG1018, O/W 1849101) ¸¦ °¢°¢ SARS-CoV-2 subunit vaccine °ú °áÇÕÇÏ¿© »ç¿ëÇßÀ» ¶§, ¸é¿ª¹ÝÀÀ È°¼ºÈ Á¤µµ¸¦ ºñ±³ÇÑ ³í¹®ÀÔ´Ï´Ù. ƯÀÌÀûÀ¸·Î CpG1018 °ú AS37 Àº Th1 CD4+ T cell resposne ¸¦, alum, O/W, AS03 ÀÇ °æ¿ì Th1/Th2 response ¸¦ ³ªÅ¸³Â½À´Ï´Ù. ¶ÇÇÑ adjuvant ¿¡ ÀÇÇØ Ãʱâ innate response µµ ±¸º°µÇ´Â Â÷À̸¦ º¸¿´À¸¸ç SARS-CoV-2 ÀÇ variant (B.1.351) ¿¡ ´ëÇؼµµ °¢ adjuvant ÀÇ nAb response, protection Á¤µµ¸¦ ºñ±³Çß½À´Ï´Ù.
SARS-CoV-2 ¹é½Å, adjuvant ½ÇÇèµðÀÚÀÎÀ» °øºÎÇغ¸°íÀÚ ¼±Á¤Çß½À´Ï´Ù.
Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
³í¹®»çÀÌÆ®: Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice | npj Vaccines (nature.com)